The Role of Meat-borne Carcinogens in Pancreatic Cancer
Status:
Withdrawn
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
We propose to recruit subjects scheduled for pancreatectomy as a treatment for pancreatic
cancer. These subjects will ingest a very low dose of radiolabeled PhIP, a meat-derived
carcinogen, and a small amount of resected tissue (waste) will be analyzed with highly
sensitive technology to determine if this carcinogen binds to DNA in the pancreas.
Phase:
Phase 1
Details
Lead Sponsor:
University of Minnesota University of Minnesota - Clinical and Translational Science Institute
Collaborators:
Lawrence Livermore National Laboratory University of Arkansas